Muscle Stimulator Market Insights 2030:
The global muscle stimulator market size was valued at $1,22,460.00 thousand in 2020, and is projected to reach $1,83,887.64 thousand by 2030, registering a CAGR of 4.08% from 2021 to 2030. Electrical muscle stimulation (EMS) is the elicitation of muscle contraction using electric impulses. Electrical muscle stimulation has gained high traction in the last few years, as it is utilized as a strength training tool for healthy subjects and athletes. In addition, it is used as a rehabilitation and preventive tool for people who are partially or totally immobilized. Moreover, it serves as a testing tool for evaluating the neural and/or muscular function in vivo as well as a post-exercise recovery tool for athletes.
The growth of the global muscle stimulator market is driven by increase in popularity of sports coupled with surge in demand for fitness products, rise in geriatric population, and upsurge in incidence of musculoskeletal & neuromuscular disorders. In addition, rise in awareness of electrical muscle stimulation therapies and increase in preference among physiotherapists about electrical muscle stimulation contribute toward growth of the muscle stimulator market. However, lack of usage guidelines and safety concerns, regulatory uncertainties in the U.S. and availability of alternative therapies restrain the market growth. Conversely, development of wireless portable muscle stimulators is expected to offer lucrative opportunities during the forecast period.
Impact Of Covid-19 On Muscle Stimulator Market (Pre And Post Analysis)
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. Supply chains were disrupted due to restrictions on trade of pharmaceutical ingredients and products across countries. In addition, COVID 19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the muscle stimulator market. During the COVID-19 pandemic 2020, there was a significant reduction in many types of outpatient tests and treatments, with surgical treatments.
Several market players experienced a revenue drop in the stimulators platform, due to the COVID. For instance, in the fiscal year 2019-2020, Neurometrix Inc. registered decrease in net sales by 20% The drop in sales of Altis single-incision slings and other goods was mostly due to the cancellation of elective operations and treatments in the U.S. as a result of the COVID-19 outbreak. Moreover, due to the COVID-19 outbreak, the elective procedures outside the U.S. were postponed in several countries. Furthermore, the company’s commercial investments were temporarily put on hold due to the COVID-19 pandemic, due to the improved outlook for the interventional urology segment. However, this situation is expected to change post COVID-19 pandemic in the coming years.
The muscle stimulator market is segmented on the basis of product type, modality, application, end-user and region. By product type, the market is divided into neuromuscular electrical stimulation, functional electrical stimulation, interferential, burst mode alternating current, micro current electrical neuromuscular stimulator and others. By modality, the market is categorized into portable and handheld, and table top. By application, the market is categorized into pain management, muscle rehabilitation, muscle atrophy, muscle toning &strengthening, muscle spasticity & spasms, others. Furthermore, by end user, it is classified into physical therapy and rehabilitation clinics, hospitals, ambulatory surgery centers and home care. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product type Segment Review
By product type, the muscle stimulator market is segregated into neuromuscular electrical stimulation, functional electrical stimulation, interferential, burst mode alternating current, micro current electrical neuromuscular stimulator and others. The neuromuscular electrical stimulation segment generated the highest revenue in 2020. This is attributed to the growing prevalence of arthritis and increasing sports injuries. Moreover, neuromuscular electrical stimulation segment is also expected to show the fastest growth rate owing to increase in the demand of the muscle stimulation therapy in the developing countries.
By Product Type
Neuromuscular Electrical Stimulation segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.
Modality Segment Review
By modality, the portable and handheld segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period. This segment is also expected to show fastest growth rate due to the key players launching innovative portable muscle stimulator devices to sustain market competition.
Application Segment Review
By application, the muscle rehabilitation segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period. Moreover, pain management segment is expected to show fastest growth rate due to increasing cases of chronic and acute pain and the need for effective pain management therapies among cancer patients.
Pain management segment is projected as one of the most lucrative segment.
End-user Segment Review
By end user, the physical therapy and rehabilitation clinics segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period. This segment is also expected to show fastest growth rate owing to growing preference of physiotherapists toward stimulators as compared to manual techniques.
Region Segment Review
North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, well-developed healthcare infrastructure, and favorable reimbursement policies in healthcare system. However, Asia-Pacific is expected to grow at the fastest CAGR, owing to increase in number of incidences of musculoskeletal disorders and rise in awareness related to electrical muscle stimulation therapy.
Asia-Pacific would exhibit the highest CAGR of 5.52% during 2020-2030.
Key benefits for stakeholders
- This report provides a detailed quantitative analysis of the current muscle stimulator market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global muscle stimulator market is provided.
- The projections in this report are made by analyzing the current trends and future muscle stimulator market potential from 2020 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the muscle stimulator market.
Muscle Stimulator Market Report Highlights
By Product Type
By End User
By Key Market Players
The muscle stimulator market has piqued the interest of healthcare professionals, patients, and surgeons, owing to improved care of patients suffering from musculoskeletal disorders. There have been remarkable technological advancements in the development of electronic muscle stimulator devices, including PowerDot, JetStream, and Omron electric muscle stimulator devices. As the market is growing at a steady rate in the developed nations, Asia-Pacific and Europe are expected to offer high growth opportunities to the key players. In addition, patients suffering from neurological conditions such as stroke, multiple sclerosis, and cerebral palsy use muscle stimulators devices.
The factors such as rise in demand for surgical treatment of muscle stimulator targeted toward an early cure, increase in geriatric population, and rise in the muscle stimulator device types propel the market growth. Moreover, rise in research activities to exploit the advantages offered by muscle stimulator devices, surge in healthcare expenditures in developing countries, and new upgrades in the technologies offer lucrative opportunities for market growth.